Top

Indian Journal of Hematology and Blood Transfusion

12-03-2025 | Acute Promyelocytic Leukemia | Correspondence

An Untimely Occurrence of Differentiation Syndrome in APL- Better be Suspicious

Authors: Amiya Ranjan Nayak, Mukul Aggarwal, Priyanka Naranje, Jasmita Dass, Pradeep Kumar

Published in: Indian Journal of Hematology and Blood Transfusion

Excerpt

Dear Editor, …

Abaza Y, Kantarjian H, Garcia-Manero G et al (2017) Long-term outcome of acute promyelocytic leukemia treated with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab. Blood 129(10):1275–1283. https://doi.org/10.1182/blood-2016-09-736686CrossRefPubMedPubMedCentral

Montesinos P, Bergua JM, Vellenga E et al (2009) Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors. Blood 113(4):775–783. https://doi.org/10.1182/blood-2008-07-168617CrossRefPubMed

Stahl M, Martin S, Tallman (2019) Differentiation syndrome in acute promyelocytic leukaemia. Br J Haematol vol 187(2):157–162. https://doi.org/10.1111/bjh.16151

Title: An Untimely Occurrence of Differentiation Syndrome in APL- Better be Suspicious
Authors: Amiya Ranjan Nayak
Mukul Aggarwal
Priyanka Naranje
Jasmita Dass
Pradeep Kumar
Publication date: 12-03-2025
Publisher: Springer India
Keywords: Acute Promyelocytic Leukemia
Pleural Effusion
Published in: Indian Journal of Hematology and Blood Transfusion
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI: https://doi.org/10.1007/s12288-025-01985-1

Elevate your expertise in aplastic anemia (Link opens in a new window)

Aplastic Anemia
Independent Medical Education

Transform the way you care for your patients with aplastic anemia with our 3-module series using real-world case studies and expert insights. Discover why early diagnosis matters, explore the benefits and risks of current treatments, and develop tailored approaches for complex cases.

Supported by:

Pfizer

Developed by: Springer Healthcare IME

Learn more

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

Targeted Therapy
On-demand webinar

In this webinar, Professor Martin Dreyling and an esteemed international panel of CAR T-cell therapy experts discuss the latest data on the safety, efficacy, and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL.

Please note, this webinar is not intended for healthcare professionals based in the US and UK.

Podcast | Sexual health in older age

Springer Medicine

An Untimely Occurrence of Differentiation Syndrome in APL- Better be Suspicious

Excerpt

Elevate your expertise in aplastic anemia (Link opens in a new window)

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

Podcast | Sexual health in older age

Springer Medicine

Excerpt

Please log in to get access to this content

Elevate your expertise in aplastic anemia (Link opens in a new window)

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma